Heparin is considered one of the safest anticoagulants available during pregnancy. Neither unfractionated heparin (UFH) nor low-molecular-weight heparin (LMWH) crosses the placenta in significant quantities, which means the medication reaches the mother’s bloodstream without directly affecting the developing baby. That said, “safe” doesn’t mean “risk-free,” and the type of heparin, the dose, and the duration of treatment all influence what you can expect.
Why Heparin Is the Preferred Blood Thinner in Pregnancy
Pregnancy increases your risk of blood clots by four to five times compared to when you’re not pregnant. Your blood clots more easily, your growing uterus compresses veins in your pelvis, and hormonal changes slow blood flow in your legs. For women who need anticoagulation therapy during pregnancy, whether to treat an existing clot, prevent one from forming, or manage a condition like antiphospholipid syndrome, heparin-based drugs are the standard choice.
The main reason is molecular size. Heparin molecules are too large to cross the placenta in meaningful amounts, so they don’t interfere with fetal development. This is a major advantage over oral blood thinners like warfarin, which do cross the placenta and are linked to birth defects, particularly when used in the first trimester. LMWH (sold under brand names like enoxaparin and dalteparin) is typically the first choice because it has predictable dosing, doesn’t require as much blood monitoring, and has a strong safety track record. Unfractionated heparin is used when a shorter-acting drug is needed, such as close to delivery or before a planned procedure.
LMWH vs. Unfractionated Heparin
Both forms prevent clots effectively, but they differ in practical ways that matter during pregnancy.
LMWH is given as a once- or twice-daily injection under the skin, usually in the thigh or abdomen. It has a longer, more predictable duration of action, which means steadier protection and fewer required blood tests. For most of pregnancy, it’s the more convenient option. It also carries a lower risk of two significant side effects: bone density loss and a dangerous immune reaction called heparin-induced thrombocytopenia.
Unfractionated heparin acts faster and wears off faster. Its shorter half-life makes it easier to stop quickly if you go into labor unexpectedly or need an emergency procedure. It does require more frequent blood monitoring to keep levels in the right range, and it’s typically given more often throughout the day. For these reasons, some providers switch patients from LMWH to unfractionated heparin in the final weeks of pregnancy to allow more flexibility around delivery timing.
Risks to the Baby
Because heparin doesn’t cross the placenta in clinically significant amounts, it does not cause birth defects. This has been confirmed across multiple studies and is a key reason it remains the anticoagulant of choice in pregnancy. However, a small risk of bleeding at the junction where the placenta attaches to the uterus still exists with any blood thinner. This can potentially contribute to complications like placental abruption, though the overall risk is low when heparin is used at appropriate doses.
An older review of 135 published cases found higher-than-expected rates of stillbirth and prematurity in women on heparin, but those numbers reflect the underlying conditions that required anticoagulation in the first place, such as recurrent clots and autoimmune disorders, not necessarily the drug itself. Women who need heparin during pregnancy tend to have higher-risk pregnancies to begin with.
Maternal Side Effects
The most common complaint is bruising and irritation at injection sites. After months of daily injections, many women develop small, hard lumps or discolored patches on their abdomen or thighs. Rotating injection sites helps but doesn’t eliminate this entirely.
A more serious concern is heparin-induced thrombocytopenia (HIT), a paradoxical immune reaction where the drug triggers your body to destroy its own platelets, which can actually increase clotting risk. In pregnant women, this is rare, occurring in roughly 1.7 per 1,000 patients, but it requires immediate treatment if it develops. Providers typically monitor platelet counts periodically to catch any decline early.
Bone Density
Long-term use of unfractionated heparin has been linked to bone density loss, and osteoporosis is its most common serious side effect with prolonged use. This was a significant concern in the past when unfractionated heparin was the only option. The good news is that LMWH does not appear to carry the same risk. Studies comparing bone mineral density in pregnant women who received prophylactic LMWH versus those who received no anticoagulation found no significant difference between the two groups. If you’re on LMWH for the duration of your pregnancy, bone loss is not something you need to worry about at prophylactic doses.
Planning for Labor and Epidurals
One of the most practical concerns for women on heparin is how it affects their options during delivery, particularly whether they can receive an epidural. Blood thinners increase the risk of a rare but serious complication called a spinal hematoma during epidural placement, so there are strict timing rules.
If you’re on prophylactic-dose unfractionated heparin (the lower doses used for prevention), you’ll need to stop injections at least 12 hours before an epidural can be placed. For therapeutic doses, which are higher, the recommended wait is 24 hours. LMWH follows similar timing guidelines. This is why many care teams develop a plan in the final weeks of pregnancy for when to stop injections, especially if an induction or cesarean section is scheduled.
For women who go into labor spontaneously, the timing doesn’t always work out perfectly. If you had your last injection too recently, an epidural may not be an option, and you’d rely on other forms of pain management instead. Switching to unfractionated heparin near your due date gives more flexibility because it clears your system faster.
Monitoring During Treatment
How closely you’re monitored depends on the type of heparin and the stage of pregnancy. LMWH requires less oversight than unfractionated heparin, but monitoring increases in the third trimester as your blood volume expands and kidney function changes, both of which can alter how the drug works in your body.
During the third trimester, providers typically check platelet counts every two weeks and measure drug activity levels (called anti-Xa levels) monthly or more often. These blood draws help confirm that the dose is still effective without being excessive. Unfractionated heparin requires even more frequent testing because its effects are less predictable from dose to dose.
Safety During Breastfeeding
Heparin is safe to use while breastfeeding. LMWH is not excreted into breast milk in clinically relevant amounts, and unfractionated heparin, which has an even larger molecular structure, would not be expected to pass into milk or be absorbed by an infant’s digestive system. No special precautions are needed, and you can continue anticoagulation postpartum without interrupting nursing. Many women stay on heparin for six weeks or more after delivery, since clot risk remains elevated in the postpartum period.